Nancy is an accomplished senior executive and thought leader with over 20 years’ success in the healthcare and biotech industries. She is a passionate and compassionate leader of high performing teams with broad commercial leadership experience including global commercial operations, marketing, sales, sales management, and market access, across specialty and primary care.
Nancy is the Chief Executive Officer for Adhera Therapeutics, Inc. (ATRX),and also serves as an Independent Board Member for FemmePharma Consumer Health, she is on the Board of Managers for HATCH@Takeda, an Advisory Board Member for Eved, an Advisor to Innate Biologics and also serves on the Pharma Digital Health Roundtable Steering Committee.
Fueled by experiencing the power of treating chronic disease first hand, she pursued a career in healthcare and has held positions of increased responsibility in pharmaceuticals including Schering-Plough, now Merck, Wyeth, Pfizer, and Bristol-Myers Squibb where she was Head, Worldwide Commercial Operations for all priority markets and therapy areas. Nancy also has executive experience with growing small and start-up healthcare firms including Outcome Health where she was Senior Vice President, Commercial Growth and Innate Biologics where she was Chief Business Officer.